Sweeteners · Metabolic & Cardiometabolic
xylitol increases cardiovascular disease
In plain terms: Does xylitol raise your risk of heart attack and stroke?
Part of: • xylitol
An early signal resting on very little evidence — a handful of observational studies from a small number of research groups, closely related to the erythritol work. Nobody has run a trial. Worth watching, far too thin to act on.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Population patterns (Observational)
How the studies fall
What the evidence shows
The same group's follow-up (European Heart Journal 2024) reported that elevated plasma xylitol is associated with 3-year cardiovascular events and is prothrombotic in mechanistic assays — mirroring their erythritol findings.
The evidence (4)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Huang L, Huhulea E, Aifuwa E, Frishman WH, Aronow WS 2025 · Cardiol Rev | observational | mixed | moderate | Review of artificial sweeteners and CVD: xylitol among emerging but non-conclusive concerns. |
| Wölnerhanssen BK, Meyer-Gerspach AC, Arduini A, D'Alessandro A, Gronda E, Carugo S, Bonomini M, Gallieni M, Masola V, Angelillo-Scherrer A, Prosdocimi T, Lopaschuk GD 2025 · Cardiovasc Res | observational | mixed | moderate | Review ('friend or foe?'): xylitol cardiovascular signal from one group; confounded by endogenous production, not replicated like erythritol. |
| Witkowski M, Nemet I, Li XS, Wilcox J, Ferrell M, Alamri H, Gupta N, Wang Z, Tang WHW, Hazen SL 2024 · Eur Heart J | observational | supports | high | Eur Heart J: elevated plasma xylitol associated with 3-yr MACE; xylitol prothrombotic (enhanced platelet aggregation, thrombosis in vivo); ingestion markedly raised plasma xylitol. Notes sugar alcohols are also endogenously produced ~1000× lower than dietary intake. |
| Huang Z, Li A, Huang R, Shi M, Yang R, Wang W, Huang Z, Liu Y, Wu J 2025 · Molecular medicine reports | in-vitro | contradicts | low | THP-1 monocyte/macrophage model: xylitol reduced LDL-induced oxidative stress (lower ROS, MDA, NADPH-oxidase expression) via Nrf2/HO-1 activation, an antiatherogenic mechanism. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.